Co-hosts Ben Plumley and Ambassador Eric Goosby press the case for continued major investments in biomedical innovation to treat, diagnose, prevent and ultimately cure HIV disease. 

While excited by the potential of new medicines, there’s still no short term end to one of the most deadly epidemics of the modern era. A renewed strategic focus on balancing basic science with delivery and implementation is at the heart of the long term HIV response - not least the challenge of maintaining uninterrupted treatment access, especially as funding mechanisms evolve globally.

Key themes include the role of advocacy, the intersection of politics and public health, and the need to empower civil society to hold governments accountable for healthcare delivery. Ambassador Goosby outlines the necessity of building coalitions that combine public, private, and multilateral efforts to ensure sustainable healthcare solutions.

00:00:00 - Introduction: Ben Plumley and Ambassador Eric Goosby discuss the high stakes of 2025.

00:02:01 - Reflecting on misinformation: The influence of tech leaders on public health narratives.

00:05:34 - Post-2030 HIV agenda: Is the focus on research or implementation?

00:08:52 - Long-acting antiretrovirals: The promise and limitations of lenacapavir.

00:20:12 - Funding the response: Challenges of sustaining global HIV treatment.

00:31:48 - Global health diplomacy: Mobilizing new donors and local government commitments.

00:39:01 - Civil society’s role: Encouraging accountability in health investments.

00:46:25 - Closing thoughts: Shaping the future of the HIV response through collaboration.

Call to Action:

Subscribe to A Shot in the Arm Podcast on your favorite platform and join us on YouTube for more in-depth discussions. Don’t forget to like, comment, and share your thoughts on this critical global health issue.

Links and Resources:

Visit A Shot in the Arm Podcast on YouTube to stay updated.

Follow us for future episodes addressing long-term HIV response strategies and the evolving role of global health diplomacy.

Acknowledgments:

Special thanks to Erik Espera of NewsDoc Media, the John Martin Foundation, and our listeners for their ongoing support.